LifeVantage logo

LifeVantage

Stock
Stock
Ticker: LFVN
LFVN

Price

Price

CHART BY

Historical dividends and forecast

LifeVantage has so far distributed $0.145 in 2026. The next dividend will be paid on 15.12.2026


$0.192

CHART BY

Frequently asked questions

The market capitalization of LifeVantage is $60.62M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
The Price-to-Earnings (P/E) ratio (TTM) for LifeVantage is 22.19. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
LifeVantage's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $0.215. EPS indicates the company's profitability on a per-share basis.
Currently, 2 analysts cover LifeVantage's stock, with a consensus target price of $6.50. Analyst ratings provide insights into the stock's expected performance.
Over the trailing twelve months, LifeVantage reported a revenue of $172.14M.
Yes, LifeVantage is paying dividends. The next payment is scheduled for 15.12.2026, with an expected amount of .
LifeVantage's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $6.59M. EBITDA measures the company's overall financial performance.
LifeVantage has a free cash flow of $8.71M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
LifeVantage employs approximately 223 people. It operates in the Health Care sector, specifically within the Other Pharmaceuticals industry.
The free float of LifeVantage is 10.30M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$60.62M
EPS (TTM) 
$0.215
Free Float 
10.30M
P/E ratio (TTM) 
22.19
Revenue (TTM) 
$172.14M
EBITDA (TTM) 
$6.59M
Free Cashflow (TTM) 
$8.71M

Pricing

1D span
$4.814$4.88
52W span
$3.91$11.55

Analyst Ratings

The price target is $6.50 and the stock is covered by 2 analysts.

Buy

1

Hold

1

Sell

0

Information

LifeVantage Corp. engages in the identification, research, development, formulation, and sale of nutraceutical dietary supplements and personal care products. Its products include Protandim, Axio, TrueScience, PhysIQ, and Petandim. It operates through the Americas, Asia or Pacific and Europe geographical segments. The company was founded in June 1988 and is headquartered in Lehi, UT.

Employees
223
Industries
Other Pharmaceuticals
Sector
Health Care

Identifier

Primary Ticker
LFVN

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation